Key Stats

Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.50% -0.08% 41.51M 8804.40
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (All)
0.39% 146.0% 23.23M Upgrade

Basic Info

Investment Strategy
The investment seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector. The fund will typically invest in 50 – 100 health care companies. The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index S&P 1500 Health Care TR
Global Category Name Healthcare Sector Equity
YCharts Categorization Healthcare Equity
YCharts Benchmark S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR)
Prospectus Objective Specialty - Health
Fund Owner Firm Name Simplify Asset Management
Prospectus Benchmark Index
N/A 100.0%
Broad Asset Class Benchmark Index
^MSWNTR 100.0%
Manager Tenure
David Berns 1.40 yrs
Michael Taylor 1.40 yrs
Paul Kim 1.40 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 13
23.23M
-2.719B Category Low
6.230B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of February 28, 2023

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of March 28, 2023. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
--
--
--
--
--
--
-4.41%
-7.25%
7.51%
22.40%
-8.71%
27.67%
15.90%
21.82%
-18.14%
4.30%
-6.03%
20.44%
2.83%
23.22%
12.75%
19.59%
-4.93%
-3.62%
-2.69%
22.28%
5.81%
20.80%
15.56%
23.41%
-4.46%
-5.36%
-3.21%
23.26%
5.58%
21.86%
18.27%
20.56%
-5.62%
-5.47%
-2.76%
21.77%
6.28%
20.44%
13.34%
26.04%
-2.09%
-6.12%
As of March 28, 2023.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (3-29-23) 0.39%
30-Day SEC Yield (12-31-22) Upgrade
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 25.96
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of February 28, 2023

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of February 28, 2023

Asset Allocation

As of February 28, 2023.
Type % Net % Long % Short
Cash 0.52% Upgrade Upgrade
Stock 99.48% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
UnitedHealth Group Inc 7.08% 467.06 -1.17%
Regeneron Pharmaceuticals Inc 5.58% 821.51 -0.66%
Medtronic PLC 5.47% 78.86 -0.82%
Establishment Labs Holdings Inc 4.74% 67.93 -1.08%
Johnson & Johnson 4.47% 153.14 0.87%
DexCom Inc 4.46% 113.50 -0.28%
Sanofi SA ADR 4.09% 54.46 0.50%
Elevance Health Inc 3.88% 456.62 -0.42%
ResMed Inc 3.83% 213.06 -0.01%
Becton, Dickinson and Co 3.44% 243.49 0.94%

News

Headline
Wire
Time (ET)
No Data Available

Basic Info

Investment Strategy
The investment seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector. The fund will typically invest in 50 – 100 health care companies. The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index S&P 1500 Health Care TR
Global Category Name Healthcare Sector Equity
YCharts Categorization Healthcare Equity
YCharts Benchmark S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR)
Prospectus Objective Specialty - Health
Fund Owner Firm Name Simplify Asset Management
Prospectus Benchmark Index
N/A 100.0%
Broad Asset Class Benchmark Index
^MSWNTR 100.0%
Manager Tenure
David Berns 1.40 yrs
Michael Taylor 1.40 yrs
Paul Kim 1.40 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (3-29-23) 0.39%
30-Day SEC Yield (12-31-22) Upgrade
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 25.96
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of February 28, 2023

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of February 28, 2023

Fund Details

Key Dates
Inception Date 10/7/2021
Last Annual Report Date 6/30/2022
Last Prospectus Date 10/28/2022
Attributes
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

News

Headline
Wire
Time (ET)
No Data Available

Top Portfolio Holders

0 of 0